Clinical Evaluation of the Photoallergy Potential of Xenaderm Ointment

Healthpoint

Status and phase: Completed; Phase 1

Conditions: Healthy

Treatments: Other: Ointment Vehicle; Drug: Xenaderm

Study type: Interventional

Funder types: Industry

Identifiers

NCT00645164

011 101 09 002

Details and patient eligibility

About

The product is being tested to see if exposure to light causes photoallergic reactions on the skin.

Enrollment: 59 patients

Sex: All

Ages: 18+ years old

Volunteers: Accepts Healthy Volunteers

Inclusion criteria

• Healthy subjects

Exclusion criteria

• Less than 18 years

Trial design

59 participants in 1 patient group

Xenaderm

Experimental group

Description:

Subject serves as own control

Treatment:

Other: Ointment Vehicle

Drug: Xenaderm